In AML patients treated by allogeneic hematopoietic transplantation, CD34+supermobilization is a negative prognostic factor

被引：0
|
作者：
Avola, Giuseppe [1 ]
Camuglia, Maria Grazia [1 ]
Milone, Giuseppe [1 ]
机构：
[1] Azienda Osped Policlin Vittorio Emanuele, Programma Trapianto Emopoiet, I-95100 Catania, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷 / 07期
关键词：
ACUTE MYELOID-LEUKEMIA; PERIPHERAL-BLOOD; MOBILIZATION; RELAPSE; RISK;
D O I：
10.1016/j.leukres.2013.03.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：853 / 854
页数：2
相关论文
共 50 条
  • [41] Wilms’ tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
    Dao-Xing Deng
    Juan-Juan Wen
    Yi-Fei Cheng
    Xiao-Hui Zhang
    Lan-Ping Xu
    Yu Wang
    Chen-Hua Yan
    Yu-Hong Chen
    Huan Chen
    Wei Han
    Feng-Rong Wang
    Jing-Zhi Wang
    Ya-Zhen Qin
    Kai-Yan Liu
    Xiao-Jun Huang
    Xiao-Su Zhao
    Xiao-Dong Mo
    BMC Cancer, 21
  • [42] Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations
    Ciurea, Stefan O.
    Chilkulwar, Abhishek
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Patel, Keyur P.
    Khogeer, Haitham
    Shah, Abdul R.
    Randolph, Brion V.
    Perez, Jorge M. Ramos
    Popat, Uday
    Hosing, Chitra M.
    Bashir, Qaiser
    Mehta, Rohtesh
    Al-Atrash, Gheath
    Im, Jin
    Khouri, Issa F.
    Kebriaei, Partow
    Champlin, Richard E.
    BLOOD, 2018, 131 (26) : 2989 - 2992
  • [43] Immune Reconstitution following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: The Impact of Expanding CD28negative CD8+ T Cells on Relapse
    Yakoub-Agha, Ibrahim
    Saule, Pasquine
    Magro, Leonardo
    Cracco, Pascale
    Duhamel, Alain
    Coiteux, Valerie
    Bruno, Benedicte
    Dufosse, Francoise
    Jouet, Jean-Pierre
    Dessaint, Jean-Paul
    Labalette, Myriam
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (04) : 496 - 504
  • [44] Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
    Jentzsch, Madlen
    Bischof, Lara
    Ussmann, Jule
    Backhaus, Donata
    Brauer, Dominic
    Metzeler, Klaus H. H.
    Merz, Maximilian
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Herling, Marco
    Platzbecker, Uwe
    Schwind, Sebastian
    BLOOD CANCER JOURNAL, 2022, 12 (12):
  • [45] Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group
    Joris, M. M.
    Bierings, M. B.
    Egeler, R. M.
    Claas, F. H. J.
    van Rood, J. J.
    Oudshoorn, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 (05) : 677 - 683
  • [46] Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory/relapsed AML patients in NR status
    Liu, Na
    Ning, Hong-Mei
    Hu, Liang-ding
    Jiang, Min
    Xu, Chen
    Hu, Jiang-Wei
    Wang, Jun
    Li, Yu-Hang
    Li, Bo-tao
    Lou, Xiao
    Yang, Fan
    Chen, Jian-Lin
    Su, Yong-Feng
    Li, Meng
    Wang, Hong-ye
    Ren, Jing
    Feng, Yue-Qian
    Zhang, Bin
    Wang, Dan-hong
    Chen, Hu
    LEUKEMIA RESEARCH, 2015, 39 (12) : 1375 - 1381
  • [47] Comparison of Cytogenetic Clonal Evolution Patterns following Allogeneic Hematopoietic Transplantation versus Conventional Treatment in Patients at Relapse of AML
    Bacher, Ulrike
    Haferlach, Torsten
    Alpermann, Tamara
    Zenger, Melanie
    Kroger, Nicolaus
    Beelen, Dietrich W.
    Kern, Wolfgang
    Schnittger, Susanne
    Haferlach, Claudia
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (12) : 1649 - 1657
  • [48] Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation
    Scordo, Michael
    Bhatt, Valkal
    Hilden, Patrick
    Smith, Melody
    Thoren, Katie
    Cho, Christina
    Shah, Gunjan L.
    Maloy, Molly A.
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Avecilla, Scott T.
    O'Reilly, Richard J.
    Castro-Malaspina, Hugo
    Tamari, Roni
    Shaffer, Brian C.
    Boelens, Jaap J.
    Perales, Miguel-Angel
    Giralt, Sergio A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (08) : 1526 - 1535
  • [49] Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Maffini, Enrico
    Labopin, Myriam
    Kroeger, Nicolaus
    Finke, Juergen
    Stelljes, Matthias
    Schroeder, Thomas
    Einsele, Herman
    Tischer, Johanna
    Bornhaeuser, Martin
    Bethge, Wolfgang
    Brecht, Arne
    Roesler, Wolf
    Dreger, Peter
    Schaefer-Eckart, Kerstin
    Passweg, Jakob
    Blau, Igor Wolfgang
    Nagler, Arnon
    Ciceri, Fabio
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 983 - 990
  • [50] Prognostic Value of Hematogones in Patients With Hematopoietic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
    Mori, Hirotaka
    Koyama, Daisuke
    Sato, Yuki
    Kataoka, Yuki
    Taito, Shunsuke
    Ishio, Takashi
    Teshima, Takanori
    Yokota, Isao
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
12345